Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

ConditionsAnal Cancer Quality of Life Chemoradiation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorLudwig-Maximilians - University of Munich

About this trial

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer

Eligibility criteria

Qualifiers

histologically proven anal cancer without distant metastases

indication for definitive chemoradiation therapy based on multidisciplinary evaluation

age >=18 years

written informed consent

Disqualifiers

age < 18 years

prior systemic therapy with regard to anal cancer

distant metastases

second malignancy

Trial design

Treatments tested in this trial

EORTC QLQ C30
EORTC QLQ CR29

Treatment groups

No treatment groups listed

Locations

Department of Radiation Oncology, University Hospital, LMU Munich81377, MunichBavaria, Germany

Sponsors and collaborators

Ludwig-Maximilians - University of Munich

Lead sponsor

Source ClinicalTrials.gov